
U.S.-based Carlyle Group Inc recently announced that it has agreed to buy a 20% stake in the pharmaceutical unit of Indian conglomerate Piramal Enterprises Ltd for about $490mn. Both the companies have jointly announced the transaction in a statement. Piramal Pharma in a statement said that it will use the capital injection to accelerate its…